Table 2 The medications of the patients with RA-ILD
Medicine | Ever used for RA or ILD N (%) | Used at the time of ILD diagnosis N (%) | Discontinued due to ILD diagnosis N (%) |
|---|---|---|---|
Prednisolone | 54 (91.5) | 10 (16.9) | 0 (0.0) |
Azathioprine | 42 (71.2) | 8 (13.6) | 0 (0.0) |
Methotrexate | 35 (59.3) | 15 (25.4) | 9 out of 15 (60.0) |
Hydroxychloroquine | 47 (79.7) | 16 (27.1) | 0 (0.0) |
Sulfasalazine | 45 (76.3) | 16 (27.1) | 2 out of 16 (12.5) |
Leflunomide | 12 (20.3) | 2 (3.4) | 2 out of 2 (100.0) |
Penicillamine | 5 (8.5) | ||
Mycophenolate Mofetil | 7 (11.9) | ||
Sodium aurothiomalate | 32 (54.2) | 7 (11.9) | 0 (0.0) |
Cyclosporin | 15 (25.4) | ||
Cyclophosphamide | 13 (22.0) | ||
Chlorambucil | 5 (8.5) | ||
Podophyllotoxin | 24 (40.7) | 7 (11.9) | 0 (0.0) |
Etanercept | 6 (10.2) | ||
Infliximab | 2 (3.4) | ||
Golimumab | 0 (0.0) | ||
Adalimumab | 5 (8.5) | ||
Abatacept | 1 (1.7) | ||
Rituximab | 11 (18.6) | 1 (1.7) | 0 (0.0) |
Tocilizumab | 1 (1.7) |